Cell Reports · 2023 · 19 citations · 61 references
MedicineGeneticsOncologyCancer GeneticsEpigeneticsMolecular OncologyCancer EpigeneticsCancer ProgressionEpigenetic Alterations In CancerEpigenetic Regulation In CancerTherapeutic ResistanceTumor Suppressor GenesEpigenetic Drug ResistanceGene Silencing In CancerGenetic Alterations In ResistanceH3k27 TrimethylationHistone MethylationMolecular Drug ResistanceNuclear Genome OrganizationTherapeutic Resistance Mechanisms
Acquired drug resistance is a major problem in the treatment of cancer. hTERT-immortalized, untransformed RPE-1 cells can acquire resistance to Taxol by derepressing the ABCB1 gene, encoding for the multidrug transporter P-gP. Here, we investigate how the ABCB1 gene is derepressed. ABCB1 activation is associated with reduced H3K9 trimethylation, increased H3K27 acetylation, and ABCB1 displacement from the nuclear lamina. While altering DNA methylation and H3K27 methylation had no major impact on ABCB1 expression, nor did it promote resistance, disrupting the nuclear lamina component Lamin B Receptor did promote the acquisition of a Taxol-resistant phenotype in a subset of cells. CRISPRa-mediated gene activation supported the notion that lamina dissociation influences ABCB1 derepression. We propose a model in which nuclear lamina dissociation of a repressed gene allows for its activation, implying that deregulation of the 3D genome topology could play an important role in tumor evolution and the acquisition of drug resistance.
61
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem, Neville E. Sanjana, Ella Hartenian et al. · Science · 2013 · 5.5K citations · Full text
Whole–genome characterization of chemoresistant ovarian cancer
Ann‐Marie Patch, Elizabeth L. Christie, Dariush Etemadmoghadam et al. · Nature · 2015 · 1.6K citations